Trial Outcomes & Findings for Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis (NCT NCT02534805)
NCT ID: NCT02534805
Last Updated: 2025-09-09
Results Overview
Avoidable Readmissions within 30 days.
Recruitment status
COMPLETED
Target enrollment
232 participants
Primary outcome timeframe
30 days
Results posted on
2025-09-09
Participant Flow
Participant milestones
| Measure |
Patient Buddy Subject Only/Not Dyad
No dyads enrolled in this part of the study. Only the patients (subjects) were enrolled in this part of the study, not dyads. The numbers only represent the patient enrollment numbers. Patients were given iphones loaded with the Buddy App that was used to enter medications, issues and orientation questions. They were seen at day 15 and day 30 and received a phone call day 7 and day 21 inquiring about issues that would need medical attention.
|
Standard of Care Subject Only/Not Dyad
No dyads enrolled in this part of the study. Subjects randomized to standard of care and not the Buddy App. Dyad unit not reported, only the patient/subject.
|
|---|---|---|
|
Overall Study
STARTED
|
116
|
116
|
|
Overall Study
COMPLETED
|
116
|
116
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis
Baseline characteristics by cohort
| Measure |
Patient Buddy Subject Only/Not Dyad
n=116 Participants
Subjects will be given iphones loaded with the App that will be used to enter medications, issues and orientation questions. They will be seen at day 15 and day 30 and will receive a phone call day 7 and day 21 inquiring about issues that would need medical attention
|
Standard of Care Subject Only/Not Dyad
n=116 Participants
Subjects randomized to standard of care and not the Buddy App
|
Total
n=232 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.1 Years
STANDARD_DEVIATION 12.38 • n=39 Participants
|
58.42 Years
STANDARD_DEVIATION 8.89 • n=41 Participants
|
58.8 Years
STANDARD_DEVIATION 10.6 • n=35 Participants
|
|
Sex: Female, Male
Female
|
58 Participants
n=39 Participants
|
40 Participants
n=41 Participants
|
98 Participants
n=35 Participants
|
|
Sex: Female, Male
Male
|
58 Participants
n=39 Participants
|
76 Participants
n=41 Participants
|
134 Participants
n=35 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
6 Participants
n=39 Participants
|
6 Participants
n=41 Participants
|
12 Participants
n=35 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
110 Participants
n=39 Participants
|
110 Participants
n=41 Participants
|
220 Participants
n=35 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race (NIH/OMB)
Black or African American
|
53 Participants
n=39 Participants
|
36 Participants
n=41 Participants
|
89 Participants
n=35 Participants
|
|
Race (NIH/OMB)
White
|
63 Participants
n=39 Participants
|
80 Participants
n=41 Participants
|
143 Participants
n=35 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=39 Participants
|
0 Participants
n=41 Participants
|
0 Participants
n=35 Participants
|
|
Region of Enrollment
United States
|
116 participants
n=39 Participants
|
116 participants
n=41 Participants
|
232 participants
n=35 Participants
|
PRIMARY outcome
Timeframe: 30 daysAvoidable Readmissions within 30 days.
Outcome measures
| Measure |
Patient Buddy Subject Only/Not Dyad
n=116 Participants
Only the patients (subjects) were enrolled in this part of the study, not dyads. The numbers only represent the subject enrollment numbers. Subjects were given phones loaded with the Buddy App, which was used to enter medications, issues, and orientation questions. They were seen on days 15 and 30 and received phone calls on days 7 and 21 inquiring about issues that would need medical attention.
|
Standard of Care Subject Only/Not Dyad
n=116 Participants
Subjects randomized to standard of care and not the Buddy App. Just the patients counted and reported, not the dyads.
|
|---|---|---|
|
Avoidable Readmission
|
23 Number of Avoidable Readmissions
|
12 Number of Avoidable Readmissions
|
Adverse Events
Patient Buddy Subject Only/Not Dyad
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Standard of Care Subject Only/Not Dyad
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place